The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Edgewise Therapeutics Inc (NASDAQ: EWTX) was $26.13 for the day, up 2.91% from the previous closing price of $25.39. In other words, the price has increased by $2.91 from its previous closing price. On the day, 1.15 million shares were traded.
Ratios:
Our analysis of EWTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 26.35 and its Current Ratio is at 26.35. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on January 22, 2025, initiated with a Hold rating and assigned the stock a target price of $30.
On November 22, 2024, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $45.
On March 07, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $48.Piper Sandler initiated its Overweight rating on March 07, 2024, with a $48 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 05 ’25 when Russell Alan J sold 8,015 shares for $30.02 per share. The transaction valued at 240,623 led to the insider holds 14,863 shares of the business.
Russell Alan J sold 1,200 shares of EWTX for $36,153 on Feb 06 ’25. The Chief Scientific Officer now owns 14,863 shares after completing the transaction at $30.13 per share. On Feb 05 ’25, another insider, KOCH KEVIN, who serves as the President and CEO of the company, sold 8,636 shares for $30.03 each. As a result, the insider received 259,298 and left with 14,478 shares of the company.
Stock Price History:
Over the past 52 weeks, EWTX has reached a high of $38.12, while it has fallen to a 52-week low of $14.90. The 50-Day Moving Average of the stock is -7.12%, while the 200-Day Moving Average is calculated to be 6.96%.
Shares Statistics:
A total of 94.41M shares are outstanding, with a floating share count of 65.86M. Insiders hold about 30.45% of the company’s shares, while institutions hold 76.48% stake in the company.
Earnings Estimates
Edgewise Therapeutics Inc (EWTX) is currently under the scrutiny of 8.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.39, with high estimates of -$0.34 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$1.39 and -$1.63 for the fiscal current year, implying an average EPS of -$1.49. EPS for the following year is -$1.86, with 8.0 analysts recommending between -$1.51 and -$2.28.
